Media Summary: Capital 10X interviews James Lanthier CEO of We spoke with James Lanthier, CEO and Joseph Araujo Chief Scientific Officer of Episode 5 - June 10th 2020 James Lanthier - CEO at

Greenshoe Minute Mindset Pharma Inc - Detailed Analysis & Overview

Capital 10X interviews James Lanthier CEO of We spoke with James Lanthier, CEO and Joseph Araujo Chief Scientific Officer of Episode 5 - June 10th 2020 James Lanthier - CEO at

Photo Gallery

Greenshoe Minute - Mindset Pharma Inc. (MSET:CSE)
Greenshoe Minute Commercial - Mindset Pharma Inc. (MSET:CSE)
Corporate Overview of Mindset Pharma Inc. from James Lanthier- CEO
Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!
Mindset Pharma Halftime Report 2022
CSE Welcome Mindset Pharma Inc.-CSE:MSET
Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery
Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering
Mindset Pharma receives Notice of Allowance for psilocin derivatives patent application
Psychedelic Insights: Mindset Pharma - James Lanthier CEO
Psychedelic Company Partnering With CAMH | Mindset Pharma
Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin
Sponsored
Sponsored
View Detailed Profile
Greenshoe Minute - Mindset Pharma Inc. (MSET:CSE)

Greenshoe Minute - Mindset Pharma Inc. (MSET:CSE)

Greenshoe Minute

Greenshoe Minute Commercial - Mindset Pharma Inc. (MSET:CSE)

Greenshoe Minute Commercial - Mindset Pharma Inc. (MSET:CSE)

Greenshoe Minute

Sponsored
Corporate Overview of Mindset Pharma Inc. from James Lanthier- CEO

Corporate Overview of Mindset Pharma Inc. from James Lanthier- CEO

Mindset Pharma

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

About

Mindset Pharma Halftime Report 2022

Mindset Pharma Halftime Report 2022

About

Sponsored
CSE Welcome Mindset Pharma Inc.-CSE:MSET

CSE Welcome Mindset Pharma Inc.-CSE:MSET

Canadian Securities Exchange welcome

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma

Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering

Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering

Mindset Pharma Inc

Mindset Pharma receives Notice of Allowance for psilocin derivatives patent application

Mindset Pharma receives Notice of Allowance for psilocin derivatives patent application

Mindset Pharma Inc

Psychedelic Insights: Mindset Pharma - James Lanthier CEO

Psychedelic Insights: Mindset Pharma - James Lanthier CEO

Capital 10X interviews James Lanthier CEO of

Psychedelic Company Partnering With CAMH | Mindset Pharma

Psychedelic Company Partnering With CAMH | Mindset Pharma

Mindset Pharma Inc

Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin

Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin

Mindset Pharma Inc

Dr. Malik Slassi from Mindset Pharma at Psychedelic Capital, July 2020 | Microdose

Dr. Malik Slassi from Mindset Pharma at Psychedelic Capital, July 2020 | Microdose

Dr. Malik Slassi, Scientific Advisor to

Mindset Pharma says US Patent and Trademark Office allowance underscores the strength of its IP

Mindset Pharma says US Patent and Trademark Office allowance underscores the strength of its IP

Mindset Pharma Inc

Q&A with James Lanthier, CEO of Mindset Pharma (MSET-CSE)

Q&A with James Lanthier, CEO of Mindset Pharma (MSET-CSE)

Mindset Pharma

Mindset Pharma (MSET) Announces Psilocybin Breakthrough Drug

Mindset Pharma (MSET) Announces Psilocybin Breakthrough Drug

We spoke with James Lanthier, CEO and Joseph Araujo Chief Scientific Officer of

Psychedelic Insiders #005 - James Lanthier, CEO of Mindset Pharma

Psychedelic Insiders #005 - James Lanthier, CEO of Mindset Pharma

Episode 5 - June 10th 2020 James Lanthier - CEO at

Investment Spotlight: Mindset Pharma with James Lanthier

Investment Spotlight: Mindset Pharma with James Lanthier

Mindset Pharma

Mindset adds to IP portfolio with three non-tryptamine families of next-gen psychedelic compounds

Mindset adds to IP portfolio with three non-tryptamine families of next-gen psychedelic compounds

Mindset Pharma Inc

Related Video Content

GrowthSync - levelupventures.com information

GrowthSync is an AI-driven commerce operations platform that unifies multi-channel sales, data, and workflows,...

EMTECH - levelupventures.com information

EmTech is the first tech company to unify modern central banking infrastructures for compliance and currency...

ClearCOGS - levelupventures.com information

ClearCOGS leverages AI to provide restaurants with actionable insights, optimizing operations, reducing food waste,...

Tensor9 - levelupventures.com information

Tensor9 enables secure, code-free deployment of software across cloud, on-prem, and air-gapped environments using...

Options MD - Level Up Ventures information

Options MD is a Techstars company that provides personalized care for people struggling with severe and...